$0.9700
-0.01-1.02%
At close: -
$0.9599
-0.01-1.04%
After Hours: 7:27 PM EDT
LAVA Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of LAVA Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-12-10 | $-0.46 | $-0.33 | -39.4 % |
Q2 | 2024-08-20 | $-0.31 | $-0.36 | 13.9 % |
Q1 | 2024-05-21 | $-0.02 | $-0.12 | 83.3 % |
Q4 | 2024-03-20 | $-0.24 | $-0.12 | -100.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q1 | 2024-05-21 | $6.99M | $7.00M | -0.11 % |
Q4 | 2024-03-20 | $353.00K | $6.25M | -94.3 % |
Q2 | 2023-08-22 | $5.14M | $830.00K | 519.2 % |
Q4 | 2023-04-11 | $2.64M | $250.00K | 956.0 % |
LAVA Therapeutics (LVTX) is scheduled to report earnings on March 19, 2025. The last reported earnings were for reported on December 10, 2024 for Q3.
The Actual EPS was $-0.46, which missed the estimate of $-0.33.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.